180 Life Sciences Corp (ATNF)
1.585
-0.06
(-3.94%)
USD |
NASDAQ |
May 17, 16:00
1.585
0.00 (0.00%)
After-Hours: 20:00
180 Life Sciences Free Cash Flow: -10.92M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -10.92M |
September 30, 2023 | -11.69M |
June 30, 2023 | -13.51M |
March 31, 2023 | -13.92M |
December 31, 2022 | -12.13M |
September 30, 2022 | -14.23M |
June 30, 2022 | -14.63M |
Date | Value |
---|---|
March 31, 2022 | -15.11M |
December 31, 2021 | -19.37M |
September 30, 2021 | -17.56M |
June 30, 2021 | -13.61M |
March 31, 2021 | -9.793M |
December 31, 2020 | -3.872M |
Free Cash Flow Range, Past 5 Years
-19.37M
Minimum
Dec 2021
-3.872M
Maximum
Dec 2020
-13.10M
Average
-13.61M
Median
Jun 2021
Free Cash Flow Benchmarks
Altimmune Inc | -72.76M |
Seelos Therapeutics Inc | -18.21M |
GT Biopharma Inc | -8.852M |
Outlook Therapeutics Inc | -58.26M |
MAIA Biotechnology Inc | -13.30M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -2.16M |
Cash from Financing (Quarterly) | 1.468M |
Free Cash Flow Per Share (Quarterly) | -4.040 |
Free Cash Flow Yield | -1.94K% |